At three separate events, held in Palermo, Bari and Lecce, stem cells and orphan drugs issues were analyzed and debated from the different points of view of many key players: rare disease patients and all professionals in research, treatment and government (researchers and associations, health professionals, students, institutional representatives).

The discussion also analysed the social impact of the ethics, science and economics behind stem cell research.